Redona Therapeutics specializes in the modulation of functional non-coding RNA to treat cancer and other human diseases.
Redona Therapeutics has raised $60.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2023.
Redona Therapeutics's investors include Astellas Venture Management.
Redona Therapeutics is headquartered in Watertown, United States.
Redona Therapeutics specializes in the modulation of functional non-coding RNA to treat cancer and other human diseases.
Redona Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Redona Therapeutics — Funding & Investors." VCBacked, July 31, 2023, https://www.vcbacked.co/company/redona-therapeutics. Accessed August 16, 2026.
VCBacked. (2023). Redona Therapeutics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/redona-therapeutics
{{cite web |title=Redona Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/redona-therapeutics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated